Publique en esta revista
Información de la revista
Vol. 70. Núm. 6.
Páginas 517-518 (Junio 2017)
Letter to the Editor
DOI: 10.1016/j.rec.2016.12.030
Acceso a texto completo
Liver Imaging in Patients With Fontan Circulation
Imagen hepática de pacientes con cirugía de Fontan
Efrén Martínez-Quintanaa,b,
Autor para correspondencia

Corresponding author:
, Fayna Rodríguez-Gonzálezc
a Servicio de Cardiología, Complejo Hospitalario Universitario Insular-Materno Infantil, Las Palmas de Gran Canaria, Spain
b Departamento de Ciencias Médicas y Quirúrgicas, Facultad de Ciencias de la Salud, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
c Servicio de Oftalmología, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
Contenido relaccionado
Rev Esp Cardiol. 2017;70:399-40110.1016/j.rec.2016.09.013
Susana Martín-Garre
Rev Esp Cardiol. 2017;70:518-910.1016/j.rec.2017.01.015
Susana Martín-Garre
Este artículo ha recibido
(Actualización diaria de datos)
Información del artículo
Texto completo
Descargar PDF
Texto completo
To the Editor,

We read the article published by Martín-Garre1 with interest. However, in the light of that reading, we would like to make a few comments that we believe to be important.

The Fontan procedure has been of particular benefit to infants with functional single-ventricle complexes but an inevitable consequence is systemic venous hypertension. Hepatic histology of patients with Fontan circulation usually begins with sinusoidal dilatation, parenchymal atrophy, and progressive fibrosis secondary to repetitive mechanical stretch due to persistent chronic passive venous congestion and limited cardiac output, which favors tissue hypoxia. Hepatocarcinogenesis forms part of the continuum of dedifferentiation that includes hypervascular nodules, regenerative nodules, dysplastic nodules, and hepatocellular carcinoma (HCC). Although ultrasound (US) remains inexpensive and is recommended as the first choice for the screening and surveillance of HCC by the guidelines of almost all international societies, Fontan patients have some peculiarities that must be taken into account.

First, US imaging findings in long-standing Fontan patients may be characterized by hepatomegaly, hepatic vein and suprahepatic inferior vena cava dilation, surface nodularity, increased parenchymal echogenicity, and HCC, which is usually a nodule greater than 1cm in diameter. The classic US findings of HCC include hypoechoic nodules or mixed echogenic nodules due to tumor necrosis or fatty metamorphosis or a surrounding thin hypoechoic band indicating a capsule that is characteristic of these tumors.2 In addition, as mentioned by Martín-Garre, the form of presentation of HCC may vary (multiplicity of nodules, small sized nodules, and “nodules within nodules”).

Second, standard US can assess nodularity with variable accuracy (the sensitivity and specificity for HCC diagnosis are 60% and 93%, respectively, and are even poorer for HCC less than 1cm). Doppler US may be used to assess portal vein flow and the presence of collateral vessels suggesting portal hypertension. In addition, color Doppler flow imaging may show hypervascularity and tumor vascular shunting. Nonetheless, both nodularity and portal flow changes are late findings and are not therefore helpful in detecting signs of early hepatic compromise,3 which is of particular importance due to the significant impact of even mild liver disease on the outcome of cardiac surgery. Similarly, contrast-enhanced US may improve the detection of cirrhosis and may reflect the real-time dynamics of blood supply of the lesion, which is helpful in both the detection and characterization of HCCs, but again does not accurately distinguish earlier stages of fibrosis.

Third, US may be adequate for screening cirrhosis in general but is not the preferred option in Fontan patients due to the high incidence of nonmalignant vascular lesions. In fact, the presence of arterialized nodules in Fontan patients is relatively frequent and, although these nodules are benign and pathologically identifiable as focal nodular hyperplasia, they can be confused with HCC, which is increasingly reported even in the absence of frank cirrhosis.4

Finally, although there are no data on the precise incidence of HCC, the fact that most Fontan patients have structural hepatic derangements at the initiation of screening confirms that we are initiating imaging too late. Therefore, periodic imaging should be started in childhood or early adolescence.5 The ideal screening test is gadolinium-enhanced magnetic resonance imaging (with a sensitivity and a specificity of 91% and 95%, respectively, to detect HCC)2 at intervals of 3 to 4 years. In patients with contraindications to magnetic resonance, a computed tomography scan may be performed, although the risk of radiation exposure must be considered. Meanwhile, liver stiffness estimated by US and magnetic resonance elastography techniques may be used as a quantitative imaging biomarker for the detection, staging, characterization, and monitoring of liver fibrosis. However, the use of elastography in Fontan-associated liver disease is problematic because any altered hepatic stiffness beyond fibrosis, particularly the vascular congestion universally present in Fontan patients, may have an impact on the results.

For all these reasons, some authors recommend that patients with a Fontan procedure performed more than 10 years previously should undergo cardiac assessment, liver imaging, and even liver biopsy4 to stay ahead of neoplastic transformation. Even after heart transplant, patients who have undergone the Fontan procedure will require vigilant screening for HCC.

S. Martín-Garre.
Liver and Cardiovascular Disease: What Cardiologists Need to Know About Ultrasound Findings.
Rev Esp Cardiol., 70 (2017), pp. 399-401
H. Sun, T. Song.
Hepatocellular carcinoma: Advances in diagnostic imaging.
Drug Discov Ther., 9 (2015), pp. 310-318
A. Colli, M. Fraquelli, G. Casazza, et al.
Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review.
Am J Gastroenterol., 101 (2006), pp. 513-523
J. Rychik, G. Veldtman, E. Rand, et al.
The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium.
Pediatr Cardiol., 33 (2012), pp. 1001-1012
Lindsay, J. Johnson, M.D. Everitt, J. Hoffman, A.T. Yetman.
Impact of liver disease after the fontan operation.
Am J Cardiol., 115 (2015), pp. 249-252
Copyright © 2016. Sociedad Española de Cardiología
Revista Española de Cardiología

Suscríbase a la newsletter

Opciones de artículo
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.